Tofacitinib: new type of rheumatoid arthritis treatment launches

Xeljanz (tofacitinib) is a new oral treatment option for patients with moderate to severe active rheumatoid arthritis (RA).

Existing users login here

Forgotten Password?

Need help? Email us

Not registered? Sign up now for FREE access to:

  • GP online

Registered GPs also have FREE access to:

  • MIMS online
  • MIMS print*

Sign up now

Want access to MIMS and not a GP?

Subscribe to MIMS today

*Fully qualified GPs based in NHS practices only. All other GPs can access MIMS in print by subscription